A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 1 / Phase 2	2026-08-20		NCT06785636

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Duke University	446
Pathos AI, Inc.	1

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer and Blood Research Center	Los Alamitos	United States	2
Community Health Network	Indianapolis	United States	16
Duke University Medical Center	Durham	United States	505
Emory University Hospital	Atlanta	United States	131
Johns Hopkins Hospital	Baltimore	United States	135
Karmanos Cancer Institute	Detroit	United States	153
Memorial Sloan-Kettering Cancer Center (Mskcc)	New York	United States	1
MemorialCare Orange Coast Medical Center	Fountain Valley	United States	5
Mount Sinai Medical Center	Miami	United States	1
Nebraska Cancer Specialists	Omaha	United States	40
NEXT Oncology - Virginia	Fairfax	United States	5
Ochsner	Jefferson	United States	1
Oncology Consultants, P.A	Houston	United States	1
Siteman Cancer Center	St Louis	United States	13
Taylor Cancer Research Center	Maumee	United States	24
The Ohio State University	Columbus	United States	191
University of Chicago	Chicago	United States	312
University of Colorado Health	Aurora	United States	6
University of Texas Southwestern Medical Center	Dallas	United States	249